Milestone Pharmaceuticals Inc.
NASDAQ:MIST
1.47 (USD) • At close October 17, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | Milestone Pharmaceuticals Inc. |
Symbool | MIST |
Munteenheid | USD |
Prijs | 1.47 |
Beurswaarde | 78,306,312 |
Dividendpercentage | 0% |
52-weken bereik | 1.12 - 3.52 |
Industrie | Biotechnology |
Sector | Healthcare |
CEO | Mr. Joseph G. Oliveto M.B.A. |
Website | https://www.milestonepharma.com |
An error occurred while fetching data.
Over Milestone Pharmaceuticals Inc.
Milestone Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of cardiovascular medicines. The company is developing etripamil, a novel channel blocker, which is in Phase III clinical trial for the treatment of paroxysmal supraventricular tachycardia in the United States and Canada; and Phase II clinical trial for
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (USD)
Cijfers zijn in miljoenen (USD)